Related articles

Durvalumab

Immunotherapy drug combined with tarlatamab as maintenance therapy in the DeLLphi-305 trial for small-cell lung cancer.

• Oncologists in Chicago and Madrid Erupt in Standing Ovations for Breakthroughs Against Pancreatic and Lung Cancer